BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 5,120.00
+80.00 (1.59%)
At close: May 14, 2026
BioNote Market Cap
BioNote has a market cap or net worth of 520.31 billion as of May 14, 2026. Its market cap has increased by 13.44% in one year.
Market Cap
520.31B
Enterprise Value
184.15B
Revenue
118.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,120.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 520.31B, a decrease of -52.04%. That is a compound annual growth rate of -19.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 509.20B | -8.16% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CLASSYS | 3.59T |
| SD Biosensor | 998.77B |
| T&L Co., Ltd. | 440.94B |
| Value Added Technology | 331.99B |
| Vieworks | 282.80B |
| Dongbang Medical | 164.54B |
| Shinhung | 128.17B |
| EOFLOW | 51.11B |